Edit
Impel NeuroPharma
http://www.impelneuropharma.com/Last activity: 05.12.2016
Active - Reference to Impel NeuroPharma
Total raised: $12M
Investors 1
| Date | Name | Website |
| - | Alliance o... | allianceof... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 14.10.2015 | Series B | $12M | - |
Mentions in press and media 4
| Date | Title | Description |
| 05.12.2016 | Term Sheet — Monday, December 5 | ET CETERA • A G Thing: In November Stripe announced its $150 million Series D round led by CapitalG, the growth equity investment arm of Alphabet. Existing investors General Catalyst and Sequoia Capital joined. Paid Content Securing the ent... |
| 14.10.2015 | 3M invests in Impel NeuroPharma’s drug delivery device | [Image courtesy of Impel NeuroPharma] Promoted Clinical Care Capacity Planning Learn how to manage clinical care capacity more efficiently during uncertain times. SAP Promoted This Patient Experience Checklist Is Your Key To Success in 2021... |
| 14.10.2015 | Impel NeuroPharma Closes First Tranche of $12M Series B Financing | Impel NeuroPharma Inc., a Seattle, WA-based biopharmaceutical company specializing in developing enhanced CNS products based on its proprietary Precision Olfactory Delivery (POD) technology, closed the first tranche of its $12m Series B fin... |
| - | 3M invests in Impel NeuroPharma’s drug delivery device | Proof positive that 3M is keeping tabs on the development of inhalant drug delivery products: Seattle-based Impel NeuroPharma just closed out the first tranche of a $12 million Series B round from the Minnesota conglomerate’s venture arm. T... |